发明申请
US20070049536A1 Novel compounds as inhibitors of hepatitis C virus NS3 serine protease
失效
新型化合物作为丙型肝炎病毒NS3丝氨酸蛋白酶的抑制剂
- 专利标题： Novel compounds as inhibitors of hepatitis C virus NS3 serine protease
- 专利标题（中）： 新型化合物作为丙型肝炎病毒NS3丝氨酸蛋白酶的抑制剂
-
申请号： US11542228申请日： 2006-10-03
-
公开(公告)号： US20070049536A1公开(公告)日： 2007-03-01
- 发明人: Srikanth Venkatraman , F. Njoroge , Melissa Blackman , Wanli Wu , Latha Nair , Ashok Arasappan , Stephane Bogen , Kevin Chen , Mousumi Sannigrahi , Frank Bennett , Viyyoor Girijavallabhan
- 申请人： Srikanth Venkatraman , F. Njoroge , Melissa Blackman , Wanli Wu , Latha Nair , Ashok Arasappan , Stephane Bogen , Kevin Chen , Mousumi Sannigrahi , Frank Bennett , Viyyoor Girijavallabhan
- 专利权人： Schering Corporation
- 当前专利权人： Schering Corporation
- 主分类号： A61K38/04
- IPC分类号： A61K38/04 ; C07K5/04
摘要：
The present invention discloses novel compounds which have HCV protease inhibitory activity as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising such compounds as well as methods of using them to treat disorders associated with the HCV protease.
公开/授权文献
信息查询
IPC分类:
